Consensus is 36c. Cuts FY24 revenue view to $247M-$251M from $255M-$261M, consensus $256.89M. Adjusted Operating Income is expected to be in the range of $67M-$71M. This revised guidance incorporates the impact of current conditions as of July 30, 2024, as well as consideration of potential disruptions from Lazorchak’s departure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
- Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
- Definitive Healthcare Publishes 2023 Sustainability Report